eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�.
senator: sir, i have the numbers in front of me. how can you keep this secret from the public?.
40 under 40 - bbj class of 2018.
novartis india appoints milan paleja as vice chairman and md
.
.
scottish widows has its eyes on the master trust prize.labour�s new study is based on freedom of information data from 95 english nhs trust (file pic)